Stock listing
Aktis Oncology, Inc.
Selected listing: AKTS · NASDAQ · USD · US
Aktis Oncology, Inc. (NASDAQ:AKTS), Health Technology. Latest release Sep 9, 2026: Aktis Oncology to Present at Upcoming September Investor Conferences.
- Ticker
- NASDAQ:AKTS
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Aktis Oncology, Inc.
Aktis Oncology, Inc. is a public company listed under the ticker AKTS, operating in the American market. Aktis Oncology focuses on developing innovative cancer therapies to improve patient outcomes.
Latest news from Aktis Oncology, Inc.
Aktis Oncology to Present at Upcoming September Investor Conferences
September 9, 2026
Aktis Oncology Reports Financial Results and Business Highlights for the Second Quarter 2026
August 13, 2026
Aktis Oncology to Present at the Jefferies Global Healthcare Conference
May 27, 2026
Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors
May 21, 2026
Aktis Oncology Reports Financial Results and Business Highlights for First Quarter 2026
May 11, 2026
Events
Research Aktis Oncology, Inc.
Aktis Oncology, Inc. company profile
View the public company page for Aktis Oncology, Inc. on 6ix.
Aktis Oncology, Inc. news
Read company news and market updates connected to Aktis Oncology, Inc..
Aktis Oncology, Inc. investor events
Find investor webinars, events, and replay context for Aktis Oncology, Inc..